Maternal arsenic exposure and gestational diabetes and glucose intolerance in the New Hampshire birth cohort study

Environmental Health: A Global Access Science Source

Volumn 15, Issue 1, 2016, Pages 1-8

  Farzan, Shohreh F ^a   Gossai, Anala ^b   Chen, Yu ^c   Chasan Taber, Lisa ^d   Baker, Emily ^b   Karagas, Margaret ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Arsenic; Gestational diabetes; Glucose intolerance; New Hampshire; Pregnancy cohort

Indexed keywords

ARSENIC; WELL WATER; GROUND WATER; POLLUTANT;

ARSENIC; BIOMARKER; CHILD HEALTH; COHORT ANALYSIS; DIABETES; GLUCOSE; OBESITY; POLLUTION EXPOSURE; PREGNANCY; WELL WATER; WOMENS HEALTH;

ADULT; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); FEMALE; GLUCOSE INTOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL EXPOSURE; MEDICAL HISTORY; NAIL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; URINE; ANALYSIS; CHEMISTRY; DIABETES, GESTATIONAL; ENVIRONMENTAL MONITORING; METABOLISM; NEW HAMPSHIRE; ODDS RATIO; POLLUTANT; PREGNANCY; WATER SUPPLY;

NEW HAMPSHIRE; UNITED STATES;

ADULT; ARSENIC; COHORT STUDIES; DIABETES, GESTATIONAL; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; GLUCOSE INTOLERANCE; GROUNDWATER; HUMANS; MATERNAL EXPOSURE; NAILS; NEW HAMPSHIRE; OBESITY; ODDS RATIO; PREGNANCY; WATER SUPPLY;

EID: 84994634492     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/s12940-016-0194-0     Document Type: Article

References (52)

1. Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Kirmeyer S, Mathews TJ, et al. Births: final data for 2009. In: National vital statistics reports. vol. 60: U.S. Department of Health and Human Services Centers for Disease Control and Prevention. 2012. p. 1-66.
2. DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis. 2014;11:E104.
3. HAPO Study Collective Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453-9.
4. HAPO Study Collective Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.
5. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773-9.
6. Dabelea D, Mayer-Davis EJ, Lamichhane AP, D'Agostino Jr RB, Liese AD, Vehik KS, et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care. 2008;31(7):1422-6.
7. Kelstrup L, Damm P, Mathiesen ER, Hansen T, Vaag AA, Pedersen O, et al. Insulin resistance and impaired pancreatic beta-cell function in adult offspring of women with diabetes in pregnancy. J Clin Endocrinol Metab. 2013;98(9):3793-801.
8. Nehring I, Chmitorz A, Reulen H, von Kries R, Ensenauer R. Gestational diabetes predicts the risk of childhood overweight and abdominal circumference independent of maternal obesity. Diabet Med. 2013;30(12):1449-56.
9. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care. 1995;18(5):611-7.
10. National Research Council. Critical aspects of EPA's IRIS assessment of inorganic arsenic: interim report. Washington, DC: National Research Council; 2014.
11. Karagas MR, Stukel TA, Tosteson TD. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int J Hyg Environ Health. 2002;205(1-2):85-94.
12. Kuo CC, Moon K, Thayer KA, Navas-Acien A. Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep. 2013;13(6):831-49.
13. Sung TC, Huang JW, Guo HR. Association between arsenic exposure and diabetes: a meta-analysis. Biomed Res Int. 2015;2015:368087.
14. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J, et al. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect. 2012;120(12):1658-70.
15. Tseng CH. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol. 2004;197(2):67-83.
16. Farzan SF, Chen Y, Wu F, Jiang J, Liu M, Baker E, et al. Blood pressure changes in relation to arsenic exposure in a U.S. pregnancy cohort. Environ Health Perspect. 2015;123(10):999-1006.
17. Farzan SF, Li Z, Korrick SA, Spiegelman D, Enelow R, Nadeau K, et al. Infant infections and respiratory symptoms in relation to arsenic exposure in a U.S. cohort. Environ Health Perspect. 2015;124(6):840-7.
18. Nadeau KC, Li Z, Farzan S, Koestler D, Robbins D, Fei DL, et al. In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort. Clin Immunol. 2014;155(2):188-97.
19. Rahman A, Vahter M, Ekstrom EC, Persson LA. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect. 2011;119(5):719-24.
20. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, et al. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 2009;185(3):197-202.
21. Ettinger AS, Zota AR, Amarasiriwardena CJ, Hopkins MR, Schwartz J, Hu H, et al. Maternal arsenic exposure and impaired glucose tolerance during pregnancy. Environ Health Perspect. 2009;117(7):1059-64.
22. Shapiro GD, Dodds L, Arbuckle TE, Ashley-Martin J, Fraser W, Fisher M, et al. Exposure to phthalates, bisphenol A and metals in pregnancy and the association with impaired glucose tolerance and gestational diabetes mellitus: The MIREC study. Environ Int. 2015;83:63-71.
23. Peng S, Liu L, Zhang X, Heinrich J, Zhang J, Schramm KW, et al. A nested case-control study indicating heavy metal residues in meconium associate with maternal gestational diabetes mellitus risk. Environ Health. 2015;14:19.
24. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V, et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol. 2000;152(1):84-90.
25. Whiteman VE, Salemi JL, Mejia De Grubb MC, Ashley Cain M, Mogos MF, Zoorob RJ, et al. Additive effects of Pre-pregnancy body mass index and gestational diabetes on health outcomes and costs. Obesity. 2015;23(11):2299-308.
26. Shin D, Song WO. Prepregnancy body mass index is an independent risk factor for gestational hypertension, gestational diabetes, preterm labor, and small- and large-for-gestational-age infants. J Matern Fetal Neonatal Med. 2015;28(14):1679-86.
27. Liu L, Hong Z, Zhang L. Associations of prepregnancy body mass index and gestational weight gain with pregnancy outcomes in nulliparous women delivering single live babies. Sci Rep. 2015;5:12863.
28. Schummers L, Hutcheon JA, Bodnar LM, Lieberman E, Himes KP. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol. 2015;125(1):133-43.
29. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ, et al. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci U S A. 2011;108(51):20656-60.
30. American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2016;39(Supplement 1):S94-8.
31. Committee on Practice. Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 Pt 1):406-16.
32. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014;37(Supplement 1):S14-80.
33. Le XC, Lu XF, Ma MS, Cullen WR, Aposhian HV, Zheng BS. Speciation of key arsenic metabolic intermediates in human urine. Anal Chem. 2000;72(21):5172-7.
34. Wei HY, Brockhoff-Schwegel CA, Creed JT. A comparison of urinary arsenic speciation via direct nebulization and on-line photo-oxidation-hydride generation with IC separation and ICP-MS detection. J Anal At Spectrom. 2001;16(1):12-9.
35. Larsen EH, Pritzl G, Hansen SH. Speciation of 8 arsenic compounds in human urine by high-performance liquid-chromatography with inductively-coupled plasma-mass spectrometric detection using antimonate for internal chromatographic standardization. J Anal At Spectrom. 1993;8(4):557-63.
36. Tseng CH. A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol. 2009;235(3):338-50.
37. Davis MA, Li Z, Gilbert-Diamond D, Mackenzie TA, Cottingham KL, Jackson BP, et al. Infant toenails as a biomarker of in utero arsenic exposure. J Expos Sci Environ Epidemiol. 2014;24(5):467-73.
38. Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, Eunus M, et al. A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environ Health Perspect. 2013;121(7):832-8.
39. World Health Organization. Global Database on Body Mass Index. 2016. http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/data-and-statistics. Accessed 08 Mar 2016
40. Navas-Acien A, Nachman KE. Public health responses to arsenic in rice and other foods. JAMA Intern Med. 2013;173(15):1395-6.
41. Hall M, Chen Y, Ahsan H, Slavkovich V, van Geen A, Parvez F, et al. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology. 2006;225(2-3):225-33.
42. National Research Council. Arsenic in drinking water. Washington, DC: National Academies Press; 1999.
43. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, et al. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect. 2011;119(2):258-64.
44. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr. 2006;84(5):1093-101.
45. Fleisch AF, Gold DR, Rifas-Shiman SL, Koutrakis P, Schwartz JD, Kloog I, et al. Air pollution exposure and abnormal glucose tolerance during pregnancy: the project Viva cohort. Environ Health Perspect. 2014;122(4):378-83.
46. Hu H, Ha S, Henderson BH, Warner TD, Roth J, Kan H, et al. Association of atmospheric particulate matter and ozone with gestational diabetes mellitus. Environ Health Perspect. 2015;123(9):853-9.
47. Robledo CA, Mendola P, Yeung E, Mannisto T, Sundaram R, Liu D, et al. Preconception and early pregnancy air pollution exposures and risk of gestational diabetes mellitus. Environ Res. 2015;137:316-22.
48. Hay Jr WW. Care of the infant of the diabetic mother. Curr Diab Rep. 2012;12(1):4-15.
49. Silverman BL, Rizzo T, Green OC, Cho NH, Winter RJ, Ogata ES, et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes. 1991;40 Suppl 2:121-5.
50. Sultan SA, Liu W, Peng Y, Roberts W, Whitelaw D, Graham AM. The role of maternal gestational diabetes in inducing fetal endothelial dysfunction. J Cell Physiol. 2015;230(11):2695-705.
51. West NA, Crume TL, Maligie MA, Dabelea D. Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia. 2011;54(3):504-7.
52. Pontiroli AE, Capra F, Veglia F, Ferrari M, Xiang KS, Bell GI, et al. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol. 1996;33(3):193-7.